Literature DB >> 16562589

Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment.

Amnon Zung1, Galia Barash, Zvi Zadik, Judith Barash.   

Abstract

OBJECTIVE: To evaluate the effect of disease severity and colchicine treatment on height and weight parameters in children with familial Mediterranean fever (FMF).
METHODS: Thirty prepubertal children (19 M, 11 F) were studied retrospectively. Z-score values of height, growth velocity, weight and body mass index were obtained over 1.84 +/- 1.14 years before and 2.58 +/- 1.55 years during colchicine therapy. Disease severity was evaluated by a specific score for FMF.
RESULTS: By comparison to growth before treatment, during colchicine therapy height SDS increased from -1.00 +/- 1.17 to -0.54 +/- 0.96 (p < 0.001) and weight SDS increased from -0.74 +/- 1.09 to -0.47 +/- 1.06 (p = 0.008). An effect of disease severity on growth pattern could not be detected. Height SDS during therapy was negatively correlated with age at colchicine initiation.
CONCLUSIONS: Colchicine therapy has a positive effect on both height and weight parameters in children with FMF. Early initiation of treatment is beneficial for height gain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16562589     DOI: 10.1515/jpem.2006.19.2.155

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever.

Authors:  Rabia Miray Kişla Ekinci; Sibel Balci; Eray Akay; Dilek Doğruel; Derya Ufuk Altintaş; Mustafa Yilmaz
Journal:  Arch Rheumatol       Date:  2019-01-28       Impact factor: 1.472

Review 2.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

3.  The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.

Authors:  Tuba Çelen Yoldaş; Nilgün Çakar; Özge Başaran; Banu Acar; Nermin Uncu; F Şemsa Çaycı
Journal:  Clin Rheumatol       Date:  2015-09-18       Impact factor: 2.980

4.  The effect of colchicine on physical growth in children with familial mediterranean fever.

Authors:  Z Birsin Ozçakar; Gülsüm Kadioğlu; Zeynep Siklar; Asli Kavaz; F Nur Aksanal; Merih Berberoğlu; Mesiha Ekim; Gönül Ocal; Fatoş Yalçinkaya
Journal:  Eur J Pediatr       Date:  2009-12-17       Impact factor: 3.183

5.  The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever.

Authors:  Betul Sozeri; Nesrin Gulez; Malik Ergin; Erkin Serdaroglu
Journal:  Mol Cell Pediatr       Date:  2016-08-15

6.  Immunological Evaluation in Patients with Familial Mediterranean fever.

Authors:  Shams Kholoussi; Naglaa Kholoussi; Moushira Erfan Zaki; Hala T El-Bassyouni; Hala Elnady; Botros Morcos; Asem Abo-Shanab
Journal:  Open Access Maced J Med Sci       Date:  2018-02-09

7.  Prediction of More Severe MEFV Gene Mutations in Childhood.

Authors:  Seviye Güneş-Yılmaz; Belde Kasap-Demir; Eren Soyaltın; Gökçen Erfidan; Özgür Özdemir-Şimşek; Seçil Arslansoyu-Çamlar; Demet Alaygut; Fatma Mutlubaş
Journal:  Turk Arch Pediatr       Date:  2021-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.